Search Result - Primary Antibodies

  • anti-CD25 antibody [MEM-181] (APC)
  • Cat. No: ARG53800  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone MEM-181 reacts with CD25 (Interleukin-2 receptor alpha chain), a 55 kDa type I transmembrane glycoprotein expressed on activated B and T lymphocytes, activated monocytes/macrophages and on CD4+ T lymphocytes (T regulatory cells); it is lost on resting B and T lymphocytes.
    HLDA VI; WS Code NL N-L024
  • Conjugation: APC
  • anti-CD25 antibody [MEM-181] (PE)
  • Cat. No: ARG53801  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone MEM-181 reacts with CD25 (Interleukin-2 receptor alpha chain), a 55 kDa type I transmembrane glycoprotein expressed on activated B and T lymphocytes, activated monocytes/macrophages and on CD4+ T lymphocytes (T regulatory cells); it is lost on resting B and T lymphocytes.
    HLDA VI; WS Code NL N-L024
  • Conjugation: PE
  • anti-CD26 / DPP4 antibody [BA5b] (APC)
  • Cat. No: ARG53802  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone BA5b recognizes CD26, a 110 kDa type II membrane glycoprotein, which is a peptidase expressed on mature thymocytes, T cells (especially activated), B cells, NK cells and macrophages.
    HLDA VI; WS Code N-L078
  • Conjugation: APC
  • anti-CD261 / TRAIL R1 antibody [DR-4-02] (FITC)
  • Cat. No: ARG53804  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone DR-4-02 recognizes TRAIL-R1 (DR4), a human death receptor 4 (468 amino acids) expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) and in a variety of tumour-derived cell lines.
  • Conjugation: FITC
  • anti-CD261 / TRAIL R1 antibody [DR-4-02] (PE)
  • Cat. No: ARG53805  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone DR-4-02 recognizes TRAIL-R1 (DR4), a human death receptor 4 (468 amino acids) expressed in most human tissues (spleen, peripheral blood leucocytes, thymus) and in a variety of tumour-derived cell lines.
  • Conjugation: PE
  • anti-CD262 / TRAIL R2 antibody [DR5-01-1] (FITC)
  • Cat. No: ARG53806  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone DR5-01-1 recognizes an extracellular domain of TRAIL-R2 (DR5). TRAIL-R2 is one of two TNF superfamily member intracellular death domain containing receptors for TRAIL (APO2L).
  • Conjugation: FITC
  • anti-CD262 / TRAIL R2 antibody [DR5-01-1] (PE)
  • Cat. No: ARG53807  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone DR5-01-1 recognizes an extracellular domain of TRAIL-R2 (DR5). TRAIL-R2 is one of two TNF superfamily member intracellular death domain containing receptors for TRAIL (APO2L).
  • Conjugation: PE
  • anti-CD263 / TRAIL R3 antibody [TRAIL-R3-02] (PE)
  • Cat. No: ARG53809  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone TRAIL-R3-02 reacts with TRAIL-R3, a 35 kDa GPI-anchored extracellular membrane protein expressed mainly on neutrophils.
  • Conjugation: PE
  • anti-CD264 / TRAIL R4 antibody [TRAIL-R4-01] (PE)
  • Cat. No: ARG53811  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone TRAIL-R4-01 reacts with TRAIL-R4, a 42 kDa transmembrane protein expressed on various blood cells.
  • Conjugation: PE
  • anti-CD27 antibody [LT27] (APC)
  • Cat. No: ARG53812  (Mouse mAb)
  • Reactivity: Hu
  • Application: FACS
  • Specificity: The clone LT27 reacts with CD27 (T14), a 50-55 kDa type I transmembrane glycoprotein (member of the TNF-receptor superfamily) expressed on medullary thymocytes, peripheral T lymphocytes, some B lymphocytes and NK cells.
    HLDA V; WS Code T T-CD27.01
  • Conjugation: APC